- Home
- GCEngine platform
- Solution
- Partners & Collaborations
- Company
GCEngine platform provides a dedicated tRNA Selection service to identify and optimize orthogonal tRNA decoders that match your codon strategy (UAG/UAA/UGA or quadruplet) and target ncAA. The program emphasizes orthogonality, suppression efficiency, and low background, delivering decision‑grade data and transfer‑ready constructs for preclinical R&D.
In Genetic Code Expansion (GCE), the tRNA is the decoder that determines how a reassigned codon is read at the ribosome. Achieving useful performance requires balancing:
Key engineering levers include anticodon (e.g., CUA), D-loop/T-loop/variable-loop variations, identity elements in the acceptor stem, and expression control (promoter/terminator, copy number). Selection can integrate positive/negative survival logic, ratiometric reporters, FACS-based sorting, and NGS to rank variants, with MS confirmation for site-specific incorporation where required.
Fig.1 Workflow for screening of orthogonal tRNA/synthetase pairs in E. coli. (Galles, G. D., et al., 2021)
We run a turnkey tRNA selection program covering design, build, and selection execution. Reporters and controls are standardized for comparability; suppression and background are quantified; dose and kinetics are mapped. When scoped, we integrate FACS, NGS, and MS across E. coli, yeast, and mammalian contexts to support robust, orthogonality-first engineering.
Target Definition &
Host Strategy
Codon strategy (Primarily UAG stop codon, quadruplet), target ncAA(s), and a primary host (E. coli, S. cerevisiae, or HEK293/CHO) are defined, with optional cell-free validation. Success criteria and operating assumptions are established, and the execution plan is aligned to timelines, materials, and assay dependencies for a predictable start.
Candidate Scaffold Survey & In-silico Prioritization
Orthogonal tRNA families (Pyl-type, engineered Tyr-type, archaeal scaffolds) are surveyed and prioritized by folding/identity models, sequence constraints, and known cross-reactivities. Construct strategies are proposed to match shortlisted scaffolds with the selected ncAA and codon scheme, ensuring a practicable build path.
Focused or semi-random libraries spanning anticodon (e.g., CUA for UAG), D-loop, T-loop, variable loop, and acceptor-stem elements are designed. Library size is balanced with screening throughput, and cloning schemes are finalized to enable efficient library construction and iterative selection.
Construct Build &
Expression Control
Host-optimized tRNA expression cassettes are built—bacterial native promoters, Pol III promoters (U6 or H1) for tRNA expression in mammalian systems, and yeast backbones as applicable. Copy number, processing signals, and terminators are tuned to stabilize expression while preserving orthogonality and manageable background.
Positive/Negative Selection & Reporter Screening
ncAA-dependent positive selection and counter-selection penalizing off-target charging are executed, followed by ratiometric-reporter or FACS quantification. Selection stringency and induction conditions are calibrated to maintain sensitivity and control noise, producing reliable suppression performance profiles.
Orthogonality & Crosstalk
Assessment
Orthogonality is verified with omission/swap controls (±aaRS, ±ncAA); sense-codon misreading and release-factor/codon-context effects are evaluated. Context edits and expression adjustments are tested to minimize background and preserve fidelity across relevant assay conditions.
We provide a turnkey tRNA selection service—from design through ranked, validated decoders. Contact us with your codon strategy, target ncAA(s), host, and timing; we will deliver a staged plan, milestones, and a formal quote.
A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.